At Jefferson, we are redefining humanly possible by reimagining health, education and discovery to create a fast-track to innovation. We design novel fabrics, develop new products and transform business practices. We elucidate biological pathways, develop new therapies and change healthcare delivery. In all we do, we aim to improve lives by impacting the way we think, live and care for each other.


Horizon 2020

Jefferson partners with organizations in the European Union for international research opportunities. 

DNA ALS therapy toxic protein
Featured Research

Blocking Toxic-Protein Production in ALS

An approved drug that blocks an integrated stress response shows promise in preliminary tests against ALS and frontotemporal dementia.

Research on taste smell and health
Featured Research

Monell & Jefferson Fund Five Collaborative Pilot Grants

Joint research projects focus on translating taste and smell science into healthcare outcomes